NCT00015340已完成4 期
Buprenorphine/Nx Treatment of Heroin Dependence-A Compassionate Use Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 582
- 试验地点
- 4
- 主要终点
- Craving
研究概览
简要总结
The purpose of this study is the safety and efficacy of Buprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.
详细描述
The objective of this study is to provide follow-up compassionate use treatment and evaluate long term safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment for subjects who have completed Cooperative Study 1008 A and B.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 59 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Completion of Cooperative Study 1008 A/B
排除标准
- •Significant medical or psychiatric illness. Non-compliance with study procedures in the Cooperative Study 1008 A/B
研究组 & 干预措施
Buprenorphine/Naloxone
Experimental
干预措施: Buprenorphine/naloxone (Drug)
结局指标
主要结局
Craving
Retention
Opioid withdrawal
Subjective rating
次要结局
未报告次要终点
研究者
研究点 (4)
Loading locations...
相似试验
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
已完成
不适用
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary CareHeroin DependenceOpioid-Related DisordersSubstance Abuse, IntravenousNCT00471042New York State Psychiatric Institute30
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3Heroin DependenceOpioid-Related DisordersNCT00000328University of Colorado, Denver
已完成
2 期
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9Opioid-Related DisordersNCT00000344National Institute on Drug Abuse (NIDA)40
已完成
2 期
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2Opioid-Related DisordersSubstance-Related DisordersNCT00000353National Institute on Drug Abuse (NIDA)